Nicotine and Tobacco Message Framing Among LGBT Young Adults (NCT05972941) | Clinical Trial Compass
CompletedNot Applicable
Nicotine and Tobacco Message Framing Among LGBT Young Adults
United States252 participantsStarted 2023-06-19
Plain-language summary
This trial refines and evaluates how cultural targeting influences the effectiveness of anti-tobacco messages among lesbian, gay, bisexual, and transgender (LGBT) young adults at risk for the use of more than one tobacco product (polytobacco use). Polytobacco use is associated with nicotine dependence and tobacco use into adulthood, and is disproportionately high among LGBT young adults. This trial seeks to determine how cultural targeting can be applied to communicate polytobacco use risk to at-risk LGBT young adults.
Who can participate
Age range
18 Years – 35 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Speaks English fluently
* Self-identifies as lesbian, gay, bisexual, transgender, queer, or another non- heterosexual orientation or non-binary gender identity
* Ever used e-cigarettes AND combustible cigarettes
* Currently uses e-cigarettes, combustible cigarettes, or both e-cigarettes and combustible cigarettes
* Resides in the United States
* Access to a laptop or desktop computer with a camera for virtual eye-tracking
Exclusion Criteria:
* Glaucoma
* Cataracts
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial focused on how LGBT young adults respond to different anti-tobacco messages — since it's now completed, has any published data come out that might be relevant to my situation as an LGBT person trying to quit smoking or vaping?
2The study measured things like how long people visually focused on health messages and whether those messages changed their intentions to quit — do you think findings like these could influence the kind of quit-smoking counseling or materials you'd recommend for me?
3Since this was a behavioral research study rather than a treatment trial, it didn't test any medications or therapies directly — what evidence-based quit-smoking or quit-vaping treatments would you recommend I consider right now instead of waiting for research like this to translate into clinical tools?
4The trial specifically looked at LGBT young adults, which suggests tailored messaging may matter for this group — are there any LGBT-affirming tobacco cessation programs or resources you could connect me with that might already apply insights like these?
5Because this study is completed but focused on message framing rather than medical interventions, what does my current tobacco use mean for my cancer risk, and what's the most important next step you'd recommend for my care?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Visual Attention - Dwell Time
Timeframe: During intervention on Day 1, on average 3 minutes
2
Visual Attention - Time to First Fixation
Timeframe: During intervention on Day 1, on average 3 minutes.